Important: Practice Update
We are aware of recent media reports regarding obesity drugs in relation to the central NHS press release. As is commonly the case a national press release occurs prior to services being set up. Please do NOT contact the practice enquiring about GLP1a drugs e.g. Tirzepatide (Mounjaro) for obesity / weight management. You will be advised to wait on further regional developments.
Cheshire and Merseyside ICB are scoping the commissioning of local obesity clinics to manage this process as a means of avoiding a collapse in General Practice access. As such the practice will only be prescribing these drugs for diabetic patients who meet the criteria.
https://www.cheshireandmerseyside.nhs.uk/your-health/prescribing/statements/mounjaro-tirzepatide/
Please note from 1st July 2025 we will no longer be accepting Prescription requests via email.
Popular services
